Financière de Tubize SA
EBR:TUB.BR
136.8 (EUR) • At close December 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Financière de Tubize SA |
Symbool | TUB.BR |
Munteenheid | EUR |
Prijs | 136.8 |
Beurswaarde | 6,089,323,680 |
Dividendpercentage | 1.02% |
52-weken bereik | 67.7 - 149 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. Anne Sophie Pijcke |
Website | https://www.financiere-tubize.be |
An error occurred while fetching data.
Over Financière de Tubize SA
Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide. It discovers and develops medicines and solutions in the therapeutic areas of neurology and immunology diseases. The company's products include Cimzia for treating ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)